Pathogenic bacteria infection is a major public health problem due to the high morbidity and
mortality rates, as well as the increased expenditure on patient management. Although there …

ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella
pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter …

The emergence and global spread of bacterial resistance to conventionally used antibiotics
have highlighted the urgent need for new antimicrobial agents that might replace antibiotics …

Bacterial infections and inflammation pose a severe threat to human health and the social
economy. The existence of super-bacteria and the increasingly severe phenomenon of …

Many serious infections result from persistent microbial biofilms that do not respond to
conventional antibiotic therapy. Various therapeutic approaches have been developed and …

In the recent few decades, the increase in multidrug-resistant (MDR) bacteria has reached
an alarming rate and caused serious health problems. The incidence of infections due to …

Diabetic wounds, a prevalent chronic disease, are associated with older age. The
hyperglycemic microenvironment in diabetic wounds significantly reduces the immune …

Ciprofloxacin (CIP) a broad-spectrum antibiotic, is used extensively for the treatment of
diverse infections and diseases of bacteria origin, and this includes infections caused by E …

Nanotechnology has become an emerging technology in the medical field and is widely
applicable for various clinical applications. The potential use of nanoparticles as …

Bacterial infection by ESKAPE (Enterococcus faecium, Staphylococcus aureus, Klebsiella
pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, Enterobacter spp.) …